P&G Health Stock Drops 6% Despite Q1 Profit Surge
By ThePip Desk
P&G Health shares fell 6% despite a 45.5% Q1 FY27 net profit surge to Rs 96 crore. Explore the financial highlights and market reaction.
Procter & Gamble Health Ltd. shares declined 6% on Thursday, despite the company reporting a significant 45.5% year-on-year increase in net profit for the first quarter of financial year 2027. The stock traded 5.33% lower at Rs 6,122.50 by 3 p.m. IST, contrasting with a slight gain observed in the Nifty index.
Q1 FY27 Financial Overview
The company’s net profit surged to Rs 96 crore from Rs 66 crore in the previous year, driven by several factors.
- Net Profit: Increased 45.5% year-on-year to Rs 96 crore.
- Operational PAT (excluding one-time proceeds): Rose 9% to Rs 72 crore.
- Revenue: Climbed 7.4% to Rs 364 crore from Rs 339 crore.
- Ebitda: Grew 11% to Rs 101 crore from Rs 91 crore.
- Ebitda Margin: Expanded to 27.7% from 26.8%.
Key Drivers for Profit
This substantial profit growth was attributed to strategic enhancements and a one-time financial gain.
- Strengthened supply chain.
- Enhanced go-to-market capabilities.
- One-time proceeds from the sale of an immovable asset.
Milind Thatte, Managing Director of P&G Health India, confirmed the company is achieving balanced growth and value creation. He noted this success stems from a strategy focused on a portfolio of quality, trusted brands, superiority across various aspects, constructive disruption, productivity, and an agile organization.
Broader Stock Performance
Despite Thursday’s decline, the stock has shown positive movements over longer periods.
- Year-to-date: Share price increased by 6.9%.
- Last 12 months: Share price risen by 0.89%.